Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Prevalence [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
apnea, obstructive sleep [NCBI] 0.00501411
MDD [NCBI] 0.00165333
CD [NCBI] 0.00142082
SLE [NCBI] 0.00130615
MYP2 [NCBI] 0.0010249
abdominal obesity-metabolic syndrome [NCBI] 0.000876953
cluster headache, familial [NCBI] 0.000801364
raynaud disease [NCBI] 0.000792943
plasmodium falciparum fever episodes quantitative trait locus 1 [NCBI] 0.000792943
mycobacterium tuberculosis, susceptibility to, 1 [NCBI] 0.000792943
OPA5 [NCBI] 0.000792943
migraine with or without aura, susceptibility to, 1 [NCBI] 0.000694584
BULN1 [NCBI] 0.000654288
kabuki syndrome [NCBI] 0.000550279
thyroid carcinoma, papillary, with papillary renal neoplasia [NCBI] 0.00053077
thyroid carcinoma, nonmedullary 1 [NCBI] 0.00053077
esophagitis, eosinophilic [NCBI] 0.00053077
FTSD [NCBI] 0.00053077
leprosy, susceptibility to, 1 [NCBI] 0.000433709
ATFB1 [NCBI] 0.000433709
kala-azar, susceptibility to, 1 [NCBI] 0.000371746
speech-sound disorder [NCBI] 0.000371746
asperger syndrome, susceptibility to, 1 [NCBI] 0.000371746
opioid dependence, susceptibility to, 1 [NCBI] 0.000371746
nipples, supernumerary [NCBI] 0.000371746
G6PD [NCBI] 0.000370258
torus palatinus and torus mandibularis [NCBI] 0.000326451
OPA4 [NCBI] 0.000326451
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000311082
HFM [NCBI] 0.000297285
microtia-anotia [NCBI] 0.000290975
EOCA [NCBI] 0.000290975
jejunal atresia [NCBI] 0.000290975
precocious puberty [NCBI] 0.000290975
vestibulopathy, familial [NCBI] 0.000290975
maxillonasal dysplasia, binder type [NCBI] 0.000261986
thyroid carcinoma, nonmedullary, with or without cell oxyphilia [NCBI] 0.000261986
MNG1 [NCBI] 0.000261986
DFN2 [NCBI] 0.000237607
ANON1 [NCBI] 0.000237607
prostate cancer, hereditary, 8 [NCBI] 0.000237607
CTS1 [NCBI] 0.000237607
PTH [NCBI] 0.000231849
constricting bands, congenital [NCBI] 0.000216677
behcet syndrome [NCBI] 0.000212587
dermatitis, atopic [NCBI] 0.000198423
HPCX [NCBI] 0.000198423
GBD1 [NCBI] 0.000175993
anencephaly [NCBI] 0.000167939
poland syndrome [NCBI] 0.000167939
KLK3 [NCBI] 0.000165526
VRNI [NCBI] 0.000161155
GTS [NCBI] 0.000157436
HFE [NCBI] 0.000156246
IBGC1 [NCBI] 0.000155026
CPI [NCBI] 0.000151784
glaucoma, normal tension, susceptibility to [NCBI] 0.000149133
EGF [NCBI] 0.000147972
alopecia, androgenetic [NCBI] 0.000143024
IS1 [NCBI] 0.000142881
APOE [NCBI] 0.000142224
twinning, dizygotic [NCBI] 0.000132715
PAND1 [NCBI] 0.000132715
alopecia areata 1 [NCBI] 0.000132715
FMF [NCBI] 0.000132103
aortic valve disease [NCBI] 0.000125243
MTHFR [NCBI] 0.000123356
PD [NCBI] 0.000122573
MYOC [NCBI] 0.000110959
panencephalitis, subacute sclerosing [NCBI] 0.000107101
RA [NCBI] 0.000102628
SACS [NCBI] 9.98548e-05
NF1 [NCBI] 9.95138e-05
polydactyly, preaxial i [NCBI] 9.94101e-05
MCDR1 [NCBI] 9.12697e-05
chiari malformation type i [NCBI] 9.12697e-05
VEGF [NCBI] 8.82385e-05
scleroderma, familial progressive [NCBI] 8.47515e-05
ALD [NCBI] 8.32097e-05
HHT [NCBI] 8.08164e-05
autism [NCBI] 7.89605e-05
cleft lip, congenital healed [NCBI] 7.704e-05
PPAB [NCBI] 7.704e-05
LGMD2A [NCBI] 7.65849e-05
CVS [NCBI] 7.65849e-05
FA [NCBI] 7.43763e-05
LAM [NCBI] 7.4246e-05
LDLR [NCBI] 7.30472e-05
hashimoto thyroiditis [NCBI] 7.30429e-05
PG [NCBI] 7.30193e-05
AT [NCBI] 7.24538e-05
hypospadias, autosomal [NCBI] 7.23528e-05
GJB2 [NCBI] 6.91074e-05
CAPN3 [NCBI] 6.78217e-05
MTRNR1 [NCBI] 6.78217e-05
LRRK2 [NCBI] 6.63186e-05
factor v deficiency [NCBI] 6.33772e-05
BWS [NCBI] 6.29743e-05
HCRTR2 [NCBI] 6.17811e-05
iron overload in africa [NCBI] 6.16085e-05
WAS [NCBI] 6.11715e-05
thyroid carcinoma, papillary [NCBI] 5.41108e-05
SCA6 [NCBI] 5.41108e-05
FRNS [NCBI] 5.39471e-05
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 5.30545e-05
ALB [NCBI] 5.0908e-05
CJD [NCBI] 5.02233e-05
GRA [NCBI] 5.01184e-05
sarcoidosis [NCBI] 5.00966e-05
uric acid nephrolithiasis, susceptibility to [NCBI] 4.9699e-05
kifafa seizure disorder [NCBI] 4.9699e-05
teeth present at birth [NCBI] 4.9699e-05
periodontitis, chronic [NCBI] 4.9699e-05
apert syndrome [NCBI] 4.91607e-05
ADHD [NCBI] 4.91061e-05
DHFR [NCBI] 4.74628e-05
XFS [NCBI] 4.70339e-05
TG [NCBI] 4.63014e-05
fragile x mental retardation syndrome [NCBI] 4.58922e-05
LPL [NCBI] 4.50572e-05
PNDM [NCBI] 4.42524e-05
FSCN2 [NCBI] 4.32433e-05
DWS [NCBI] 4.25916e-05
GCK [NCBI] 4.24578e-05
OPTN [NCBI] 4.20984e-05
ARMD1 [NCBI] 4.09736e-05
BRAF [NCBI] 4.00016e-05
arcus corneae [NCBI] 3.96487e-05
siderius x-linked mental retardation syndrome [NCBI] 3.96487e-05
MODY8 [NCBI] 3.96487e-05
meniere disease [NCBI] 3.96487e-05
PXE [NCBI] 3.95484e-05
APOB [NCBI] 3.75357e-05
danubian endemic familial nephropathy [NCBI] 3.7369e-05
APS1 [NCBI] 3.58894e-05
F2 [NCBI] 3.52536e-05
TPO [NCBI] 3.39941e-05
CELIAC4 [NCBI] 3.32738e-05
sarcoidosis, early-onset [NCBI] 3.32738e-05
leprosy, susceptibility to, 2 [NCBI] 3.32738e-05
ascaris lumbricoides infection, susceptibility to [NCBI] 3.32738e-05
coronary heart disease, susceptibility to, 5 [NCBI] 3.32738e-05
TSD [NCBI] 3.28671e-05
pyruvate kinase deficiency of red cells [NCBI] 3.25704e-05
CCK [NCBI] 3.18287e-05
stroke, ischemic [NCBI] 3.16213e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 3.16213e-05
MC4R [NCBI] 3.13659e-05
CLCN5 [NCBI] 3.03688e-05
MTR [NCBI] 2.94273e-05
DMD [NCBI] 2.93119e-05
PCNA [NCBI] 2.93044e-05
EGFR [NCBI] 2.90415e-05
VHL [NCBI] 2.86498e-05
ODG1 [NCBI] 2.86445e-05
CVG/MR [NCBI] 2.86445e-05
epidermolysis bullosa pruriginosa [NCBI] 2.86445e-05
isoproterenol-mediated vasodilatation [NCBI] 2.86445e-05
KRS [NCBI] 2.86445e-05
AIHHT [NCBI] 2.86445e-05
young syndrome [NCBI] 2.86445e-05
ACHE [NCBI] 2.85689e-05
OPA1 [NCBI] 2.74769e-05
AVP [NCBI] 2.72149e-05
HNF1A [NCBI] 2.71757e-05
MJD [NCBI] 2.6942e-05
homocystinuria [NCBI] 2.68313e-05
VDR [NCBI] 2.66896e-05
FABP2 [NCBI] 2.66597e-05
SMA1 [NCBI] 2.60593e-05
AIRE [NCBI] 2.60038e-05
PPR [NCBI] 2.55078e-05
DFSP [NCBI] 2.52136e-05
nonarteritic anterior ischemic optic neuropathy, susceptibility to [NCBI] 2.50433e-05
gastroschisis [NCBI] 2.50433e-05
sarcosinemia [NCBI] 2.50433e-05
OCA4 [NCBI] 2.50433e-05
thrombophilia [NCBI] 2.50433e-05
HOA [NCBI] 2.50433e-05
PJS [NCBI] 2.49035e-05
PDB [NCBI] 2.44169e-05
ABCC6 [NCBI] 2.38936e-05
NCAPG [NCBI] 2.36222e-05
ATP13A2 [NCBI] 2.36222e-05
CHEK2 [NCBI] 2.33005e-05
ADRB2 [NCBI] 2.33005e-05
SHOX [NCBI] 2.33005e-05
PCOS1 [NCBI] 2.32509e-05
PKLR [NCBI] 2.30159e-05
ATP7B [NCBI] 2.27387e-05
protoporphyria, erythropoietic [NCBI] 2.24686e-05
CORD3 [NCBI] 2.21214e-05
legg-calve-perthes disease [NCBI] 2.21214e-05
sturge-weber syndrome [NCBI] 2.21214e-05
LSFC [NCBI] 2.21214e-05
DFNB1 [NCBI] 2.20734e-05
HGF [NCBI] 2.17556e-05
leber optic atrophy [NCBI] 2.17406e-05
PRKCH [NCBI] 2.16173e-05
CH25H [NCBI] 2.16173e-05
thrombocytopenic purpura, autoimmune [NCBI] 2.15697e-05
MFS [NCBI] 2.10584e-05
MBP [NCBI] 2.02306e-05
PHF8 [NCBI] 2.01308e-05
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis [NCBI] 1.96823e-05
omphalocele [NCBI] 1.96823e-05
hyperferritinemia-cataract syndrome [NCBI] 1.96823e-05
creatine deficiency syndrome, x-linked [NCBI] 1.96823e-05
prostate cancer/brain cancer susceptibility [NCBI] 1.96823e-05
deafness, autosomal recessive [NCBI] 1.96823e-05
antiphospholipid syndrome [NCBI] 1.96823e-05
GALT [NCBI] 1.96784e-05
HMBS [NCBI] 1.96308e-05
homocysteinemia [NCBI] 1.8994e-05
HSN2 [NCBI] 1.89496e-05
HSPA1L [NCBI] 1.89496e-05
HD [NCBI] 1.81899e-05
SMAX1 [NCBI] 1.80055e-05
chromosome 17q21.31 microdeletion syndrome [NCBI] 1.79701e-05
HP [NCBI] 1.77914e-05
OCA3 [NCBI] 1.76043e-05
aspirin resistance [NCBI] 1.76043e-05
VLDLRCH [NCBI] 1.76043e-05
PRPF31 [NCBI] 1.7134e-05
SDHA [NCBI] 1.7134e-05
TNF [NCBI] 1.70342e-05
CCR5 [NCBI] 1.67055e-05
EIG [NCBI] 1.65739e-05
DRD4 [NCBI] 1.64084e-05
SACS [NCBI] 1.64052e-05
EDNRA [NCBI] 1.64052e-05
MBL2 [NCBI] 1.63404e-05
ARSA [NCBI] 1.59793e-05
JWS [NCBI] 1.58065e-05
schwannomatosis [NCBI] 1.58065e-05
hepatitis b virus, susceptibility to [NCBI] 1.58065e-05
afibrinogenemia, congenital [NCBI] 1.58065e-05
SHANK3 [NCBI] 1.57595e-05
RAMP2 [NCBI] 1.57595e-05
klippel-trenaunay-weber syndrome [NCBI] 1.55912e-05
CMD1A [NCBI] 1.55457e-05
HPS [NCBI] 1.54489e-05
MTTL1 [NCBI] 1.54358e-05
SHBG [NCBI] 1.51441e-05
OCA2 [NCBI] 1.47819e-05
CILP [NCBI] 1.46554e-05
TIMM8A [NCBI] 1.46554e-05
PRNP [NCBI] 1.44414e-05
SCZD2 [NCBI] 1.42326e-05
RP11 [NCBI] 1.42326e-05
coloboma, ocular [NCBI] 1.42326e-05
cirrhosis, familial [NCBI] 1.42326e-05
CLCN7 [NCBI] 1.41758e-05
malaria, susceptibility to [NCBI] 1.40528e-05
DRD1 [NCBI] 1.37344e-05
ICOSLG [NCBI] 1.37344e-05
MSR1 [NCBI] 1.37344e-05
glycogen storage disease ii [NCBI] 1.34108e-05
amyloidosis vi [NCBI] 1.33672e-05
OCA1A [NCBI] 1.33565e-05
FOLR1 [NCBI] 1.33258e-05
NOTCH3 [NCBI] 1.33258e-05
PLA2G7 [NCBI] 1.33258e-05
CLEC4M [NCBI] 1.33258e-05
HABP2 [NCBI] 1.33258e-05
BRCA1 [NCBI] 1.30582e-05
AGL [NCBI] 1.29456e-05
TNFRSF25 [NCBI] 1.29456e-05
COCH [NCBI] 1.29456e-05
PFC [NCBI] 1.29456e-05
LGMD2H [NCBI] 1.28416e-05
von willebrand disease, recessive form [NCBI] 1.28416e-05
PPD2 [NCBI] 1.28416e-05
myotonia congenita, autosomal recessive [NCBI] 1.28416e-05
LMNA [NCBI] 1.28132e-05
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 1.26912e-05
CEACAM5 [NCBI] 1.26166e-05
BMPR1A [NCBI] 1.25903e-05
CYBA [NCBI] 1.25903e-05
PLIN [NCBI] 1.25903e-05
THBD [NCBI] 1.25903e-05
ELAC2 [NCBI] 1.25903e-05
RNASEL [NCBI] 1.22568e-05
USH2A [NCBI] 1.22568e-05
GLDC [NCBI] 1.19429e-05
IFNA1 [NCBI] 1.18778e-05
PQBP1 [NCBI] 1.16463e-05
PCCB [NCBI] 1.16463e-05
SLC6A8 [NCBI] 1.16463e-05
wolff-parkinson-white syndrome [NCBI] 1.1603e-05
RENS1 [NCBI] 1.1603e-05
crouzon syndrome [NCBI] 1.1603e-05
pearson marrow-pancreas syndrome [NCBI] 1.1603e-05
chromosome 22q13.3 deletion syndrome [NCBI] 1.1603e-05
POAG [NCBI] 1.14468e-05
SCA2 [NCBI] 1.1152e-05
FLT3 [NCBI] 1.10988e-05
RTT [NCBI] 1.10395e-05
MODY [NCBI] 1.09045e-05
DBH [NCBI] 1.0845e-05
F12 [NCBI] 1.0845e-05
SLC5A5 [NCBI] 1.0845e-05
CAPN10 [NCBI] 1.0603e-05
PLAT [NCBI] 1.0603e-05
RPE65 [NCBI] 1.0603e-05
SDHD [NCBI] 1.0603e-05
diabetes insipidus, nephrogenic, autosomal [NCBI] 1.04933e-05
trichodentoosseous syndrome [NCBI] 1.04933e-05
JME [NCBI] 1.04933e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 1.04933e-05
tetralogy of fallot [NCBI] 1.04933e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive [NCBI] 1.04933e-05
ACHM2 [NCBI] 1.04933e-05
kaposi sarcoma [NCBI] 1.04933e-05
ISS [NCBI] 1.04933e-05
complement component 7 deficiency [NCBI] 1.04933e-05
NFNS [NCBI] 1.04933e-05
ACH [NCBI] 1.03901e-05
PINK1 [NCBI] 1.03718e-05
AD [NCBI] 1.03475e-05
BRCA2 [NCBI] 1.00577e-05
BMP15 [NCBI] 9.93831e-06
AICDA [NCBI] 9.53886e-06
DYT1 [NCBI] 9.53886e-06
IFNGR1 [NCBI] 9.53886e-06
EV [NCBI] 9.49835e-06
MS [NCBI] 9.49835e-06
vitamin d-dependent rickets, type i [NCBI] 9.49394e-06
leprosy, susceptibility to [NCBI] 9.49394e-06
alpha-thalassemia/mental retardation syndrome, deletion-type [NCBI] 9.49394e-06
SOST [NCBI] 9.49394e-06
PITX2 [NCBI] 9.3504e-06
SMPD1 [NCBI] 9.3504e-06
PON1 [NCBI] 9.25217e-06
PROS1 [NCBI] 9.16878e-06
MAFD6 [NCBI] 9.11876e-06
TNFSF6 [NCBI] 9.0899e-06
DRPLA [NCBI] 9.04546e-06
DPYD [NCBI] 8.99357e-06
thrombasthenia of glanzmann and naegeli [NCBI] 8.83843e-06
fructose intolerance, hereditary [NCBI] 8.82435e-06
MEFV [NCBI] 8.82435e-06
CETP [NCBI] 8.82435e-06
SMAD4 [NCBI] 8.82435e-06
ENPP1 [NCBI] 8.66077e-06
HLA-B [NCBI] 8.66077e-06
oca2 gene [NCBI] 8.66077e-06
MTND6 [NCBI] 8.66077e-06
RECQL3 [NCBI] 8.66077e-06
PARK6 [NCBI] 8.59022e-06
helicobacter pylori infection, susceptibility to [NCBI] 8.59022e-06
pseudoxanthoma elasticum, forme fruste [NCBI] 8.59022e-06
HSAN2 [NCBI] 8.59022e-06
SAA1 [NCBI] 8.5025e-06
CLCN1 [NCBI] 8.5025e-06
PPOX [NCBI] 8.34922e-06
RNASE3 [NCBI] 8.34006e-06
TTR [NCBI] 8.31745e-06
ACADM [NCBI] 8.24255e-06
OA1 [NCBI] 8.20068e-06
aspartylglucosaminuria [NCBI] 8.20068e-06
FGFR2 [NCBI] 8.18737e-06
XPA [NCBI] 7.91675e-06
ACADS [NCBI] 7.91675e-06
glycogen storage disease i [NCBI] 7.91675e-06
SLC26A4 [NCBI] 7.91675e-06
FGG [NCBI] 7.91675e-06
RS1 [NCBI] 7.78092e-06
PDE6B [NCBI] 7.78092e-06
neural tube defects, folate-sensitive [NCBI] 7.77016e-06
HPC1 [NCBI] 7.77016e-06
SLOS [NCBI] 7.66079e-06
DSG1 [NCBI] 7.6489e-06
GAMT [NCBI] 7.6489e-06
NOD2 [NCBI] 7.6489e-06
DES [NCBI] 7.52051e-06
SMN2 [NCBI] 7.52051e-06
GAA [NCBI] 7.39558e-06
ABCA4 [NCBI] 7.27394e-06
SCN4A [NCBI] 7.15545e-06
ENG [NCBI] 7.03997e-06
DBA [NCBI] 7.03591e-06
giant platelet syndrome [NCBI] 7.03591e-06
properdin deficiency, x-linked [NCBI] 7.0239e-06
factor xii deficiency [NCBI] 7.0239e-06
HNPP [NCBI] 7.02064e-06
NF2 [NCBI] 7.02064e-06
sickle cell anemia [NCBI] 7.02064e-06
DAZ [NCBI] 6.92736e-06
KAL1 [NCBI] 6.92736e-06
APCS [NCBI] 6.71028e-06
PCD [NCBI] 6.55218e-06
TBG [NCBI] 6.4034e-06
PCLD [NCBI] 6.34323e-06
brugada syndrome 1 [NCBI] 6.34323e-06
KAL2 [NCBI] 6.34323e-06
IBM2 [NCBI] 6.34323e-06
F13A1 [NCBI] 6.21019e-06
CYP2D6 [NCBI] 6.21019e-06
CDLS1 [NCBI] 6.15046e-06
UNG [NCBI] 6.11675e-06
AGT [NCBI] 6.11675e-06
AS [NCBI] 6.09296e-06
PROCR [NCBI] 6.0253e-06
ITGB2 [NCBI] 6.0253e-06
PSEN2 [NCBI] 5.7623e-06
PLOSL [NCBI] 5.72123e-06
EPO [NCBI] 5.70207e-06
FMR1 [NCBI] 5.66481e-06
SLC11A1 [NCBI] 5.51497e-06
KRAS [NCBI] 5.43574e-06
MTND4 [NCBI] 5.43574e-06
PKD2 [NCBI] 5.43574e-06
HNF4A [NCBI] 5.43574e-06
phenylketonuria [NCBI] 5.41247e-06
NF2 [NCBI] 5.35804e-06
ITGB3 [NCBI] 5.35804e-06
AR [NCBI] 5.27349e-06
PLG [NCBI] 5.27332e-06
RP [NCBI] 5.22397e-06
CF [NCBI] 5.20832e-06
IRS1 [NCBI] 5.20702e-06
histidinemia [NCBI] 5.15203e-06
ETM1 [NCBI] 5.15203e-06
gm1-gangliosidosis, type i [NCBI] 5.15203e-06
protein c deficiency, congenital thrombotic disease due to [NCBI] 4.92129e-06
temporal arteritis [NCBI] 4.82252e-06
VCP [NCBI] 4.59165e-06
FSHR [NCBI] 4.59165e-06
SLC4A1 [NCBI] 4.52906e-06
MAS [NCBI] 4.49585e-06
PAX6 [NCBI] 4.46751e-06
TS [NCBI] 4.4614e-06
PARK2 [NCBI] 4.40698e-06
APOA1 [NCBI] 4.34744e-06
RYR1 [NCBI] 4.34744e-06
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency [NCBI] 4.15257e-06
glycogen storage disease iii [NCBI] 4.15257e-06
USH2A [NCBI] 4.15257e-06
dystrophia myotonica 1 [NCBI] 4.01039e-06
STAT6 [NCBI] 4.00967e-06
VHL [NCBI] 3.85232e-06
UCP3 [NCBI] 3.75133e-06
JMML [NCBI] 3.73411e-06
CRMO [NCBI] 3.71419e-06
alcohol dependence [NCBI] 3.71419e-06
SPP1 [NCBI] 3.66381e-06
GBA [NCBI] 3.65332e-06
PI [NCBI] 3.57433e-06
SMN1 [NCBI] 3.55816e-06
WRN [NCBI] 3.55124e-06
prostate cancer [NCBI] 3.51347e-06
MEN1 [NCBI] 3.46571e-06
BLM [NCBI] 3.37154e-06
TLR4 [NCBI] 3.24563e-06
IL4 [NCBI] 3.16204e-06
KRT20 [NCBI] 3.08055e-06
TYR [NCBI] 3.08055e-06
porphyria variegata [NCBI] 3.0434e-06
GNRH1 [NCBI] 3.03495e-06
SCZD [NCBI] 2.99188e-06
diabetes insipidus, nephrogenic, x-linked [NCBI] 2.94352e-06
lung cancer [NCBI] 2.94352e-06
osteoarthritis [NCBI] 2.94352e-06
AFP [NCBI] 2.9338e-06
FTD [NCBI] 2.86838e-06
FBN1 [NCBI] 2.70423e-06
OFC1 [NCBI] 2.68908e-06
INS [NCBI] 2.65903e-06
MG [NCBI] 2.64629e-06
velocardiofacial syndrome [NCBI] 2.61646e-06
FHM1 [NCBI] 2.60575e-06
ABCC8 [NCBI] 2.56689e-06
CMH [NCBI] 2.50498e-06
ESR1 [NCBI] 2.5008e-06
NPM1 [NCBI] 2.43634e-06
CFH [NCBI] 2.43634e-06
PKD1 [NCBI] 2.40471e-06
UCP2 [NCBI] 2.40471e-06
PWS [NCBI] 2.40456e-06
osteogenesis imperfecta, type i [NCBI] 2.36485e-06
POMC [NCBI] 2.3306e-06
MAPT [NCBI] 2.31214e-06
musical perfect pitch [NCBI] 2.29655e-06
usher syndrome, type i [NCBI] 2.29655e-06
SPDA1 [NCBI] 2.29655e-06
lymphoma, non-hodgkin, familial [NCBI] 2.02608e-06
AVSD [NCBI] 1.88145e-06
PRL [NCBI] 1.87543e-06
RHO [NCBI] 1.87141e-06
STL1 [NCBI] 1.75588e-06
AGER [NCBI] 1.7033e-06
BCNS [NCBI] 1.6873e-06
MECP2 [NCBI] 1.63532e-06
ABCB1 [NCBI] 1.63532e-06
asthma, susceptibility to [NCBI] 1.63027e-06
ALS1 [NCBI] 1.63027e-06
IBD1 [NCBI] 1.56868e-06
F3 [NCBI] 1.56818e-06
COMT [NCBI] 1.55675e-06
DGS [NCBI] 1.53438e-06
FPLD2 [NCBI] 1.52094e-06
hypogonadotropic hypogonadism [NCBI] 1.49608e-06
PLTP [NCBI] 1.36627e-06
ADA [NCBI] 1.36354e-06
CFTR [NCBI] 1.34447e-06
gastric cancer [NCBI] 1.30757e-06
PSEN1 [NCBI] 1.29116e-06
metachromatic leukodystrophy [NCBI] 1.24143e-06
hemophilia a [NCBI] 1.21937e-06
apc gene [NCBI] 1.20192e-06
APP [NCBI] 1.11756e-06
mitochondrial complex iv deficiency [NCBI] 1.1144e-06
PGL1 [NCBI] 1.1144e-06
BBS [NCBI] 1.10847e-06
HEMB [NCBI] 1.02241e-06
KSS [NCBI] 9.55684e-07
EVA [NCBI] 9.40227e-07
SOD2 [NCBI] 8.74118e-07
ACE [NCBI] 8.55346e-07
hla-d histocompatibility type [NCBI] 8.28522e-07
drug metabolism, poor, cyp2d6-related [NCBI] 7.8392e-07
CADASIL [NCBI] 7.8392e-07
MPO [NCBI] 7.70263e-07
WBS [NCBI] 7.28792e-07
OPA1 [NCBI] 6.44463e-07
CRC [NCBI] 6.16942e-07
CVID [NCBI] 5.90358e-07
PPARA [NCBI] 5.84243e-07
JAK2 [NCBI] 5.50026e-07
LFS1 [NCBI] 5.20918e-07
CYP1A1 [NCBI] 5.0273e-07
TLR2 [NCBI] 4.92899e-07
PDS [NCBI] 4.12426e-07
GLC1A [NCBI] 4.12426e-07
CTNS [NCBI] 4.12426e-07
mucolipidosis ii [NCBI] 4.12426e-07
wilson disease [NCBI] 4.04241e-07
melanoma, uveal [NCBI] 3.18194e-07
FGF7 [NCBI] 3.15736e-07
APC [NCBI] 2.96519e-07
NPC1 [NCBI] 2.84761e-07
HBB [NCBI] 2.48407e-07
hypercholesterolemia, autosomal dominant [NCBI] 2.39546e-07
FGFR3 [NCBI] 2.34645e-07
hurler syndrome [NCBI] 2.2264e-07
HBA1 [NCBI] 1.81362e-07
ADM [NCBI] 1.76478e-07
GHR [NCBI] 1.76478e-07
TFPI [NCBI] 1.76093e-07
TP53 [NCBI] 1.48803e-07
ARPKD [NCBI] 1.19689e-07
HAE [NCBI] 1.1402e-07
SCA7 [NCBI] 7.94146e-08
WS1 [NCBI] 7.94146e-08
TNFRSF11B [NCBI] 7.54677e-08
porphyria, acute intermittent [NCBI] 7.00407e-08
RTS [NCBI] 7.00407e-08
JPS [NCBI] 7.00407e-08
XPA [NCBI] 7.00407e-08
OPMD [NCBI] 6.77411e-08
CCM [NCBI] 4.70042e-08
AN2 [NCBI] 4.70042e-08
LAD [NCBI] 3.71641e-08
SLC6A3 [NCBI] 3.27039e-08
fabry disease [NCBI] 2.97898e-08
CP [NCBI] 2.50343e-08
polycystic kidneys [NCBI] 1.92119e-08
DYT1 [NCBI] 1.48854e-08
SCS [NCBI] 1.48854e-08
SCIDX1 [NCBI] 1.48854e-08
galactosemia [NCBI] 7.07995e-09
SCA1 [NCBI] 5.08349e-09
LWD [NCBI] 2.73397e-09
FFI [NCBI] 6.34887e-10
NPS [NCBI] 2.69489e-10



Database Center for Life Science